Gliadel is a Intracavitary Wafer in the Human Prescription Drug category. It is labeled and distributed by Arbor Pharmaceuticals. The primary component is Carmustine.
| Product ID | 24338-050_38ee529a-9515-4e98-8722-5b6c848f7d74 |
| NDC | 24338-050 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Gliadel |
| Generic Name | Carmustine |
| Dosage Form | Wafer |
| Route of Administration | INTRACAVITARY |
| Marketing Start Date | 2012-12-13 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020637 |
| Labeler Name | Arbor Pharmaceuticals |
| Substance Name | CARMUSTINE |
| Active Ingredient Strength | 8 mg/1 |
| Pharm Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2012-12-13 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020637 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2012-12-13 |
| Ingredient | Strength |
|---|---|
| CARMUSTINE | 7.7 mg/1 |
| SPL SET ID: | 38962a55-a514-4c48-bea5-f99a8da4beec |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 24338-050 | Gliadel | carmustine |
| 23155-261 | BiCNU | CARMUSTINE |
| 0781-3474 | CARMUSTINE | CARMUSTINE |
| 16729-545 | CARMUSTINE | CARMUSTINE |
| 16729-548 | CARMUSTINE | CARMUSTINE |
| 23155-649 | CARMUSTINE | CARMUSTINE |
| 23155-790 | CARMUSTINE | CARMUSTINE |
| 43598-628 | carmustine | carmustine |
| 50742-492 | CARMUSTINE | carmustine |
| 54879-036 | Carmustine | Carmustine |
| 68475-503 | Carmustine | carmustine |
| 70121-1482 | carmustine | carmustine |
| 70710-1525 | carmustine | carmustine |
| 70860-223 | Carmustine | carmustine |
| 71288-126 | Carmustine | Carmustine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() GLIADEL 74006093 1650461 Live/Registered |
NOVA PHARMACEUTICAL CORPORATION 1989-11-30 |